메뉴 건너뛰기




Volumn 60, Issue 11, 2017, Pages 2285-2298

Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes

Author keywords

Diabetic retinopathy; DPP IV inhibitors; Experimental diabetes; GLP 1; Retinal neurodegeneration

Indexed keywords

ALBUMIN; COLLAGEN TYPE 4; DIPEPTIDYL PEPTIDASE IV; EVANS BLUE; EXCITATORY AMINO ACID TRANSPORTER; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUTAMIC ACID; IONISED CALCIUM BINDING ADAPTOR MOLECULE 1; MESSENGER RNA; PROTEIN AIF1; PROTEIN EPAC1; PROTEIN IBA1; SAXAGLIPTIN; SITAGLIPTIN; UNCLASSIFIED DRUG; ADAMANTANE; DIPEPTIDE; DIPEPTIDYL PEPTIDASE IV INHIBITOR;

EID: 85026802542     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-017-4388-y     Document Type: Article
Times cited : (75)

References (41)
  • 1
    • 84939262035 scopus 로고    scopus 로고
    • Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence
    • PID: 25936649
    • Simó R, Hernández C (2015) Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retin Eye Res 48:160–180
    • (2015) Prog Retin Eye Res , vol.48 , pp. 160-180
    • Simó, R.1    Hernández, C.2
  • 2
    • 84959128132 scopus 로고    scopus 로고
    • The progress in understanding and treatment of diabetic retinopathy
    • PID: 26297071
    • Stitt AW, Curtis TM, Chen M et al (2016) The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res 51:156–186
    • (2016) Prog Retin Eye Res , vol.51 , pp. 156-186
    • Stitt, A.W.1    Curtis, T.M.2    Chen, M.3
  • 3
    • 84867094327 scopus 로고    scopus 로고
    • Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications
    • PID: 22887976
    • Simó R, Hernández C, European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) (2012) Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications. Br J Ophthalmol 96:1285–1290
    • (2012) Br J Ophthalmol , vol.96 , pp. 1285-1290
    • Simó, R.1    Hernández, C.2
  • 4
    • 84859012407 scopus 로고    scopus 로고
    • Diabetic retinopathy
    • COI: 1:CAS:528:DC%2BC38XlsVClu7Y%3D, PID: 22455417
    • Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227–1239
    • (2012) N Engl J Med , vol.366 , pp. 1227-1239
    • Antonetti, D.A.1    Klein, R.2    Gardner, T.W.3
  • 5
    • 84898432100 scopus 로고    scopus 로고
    • Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment
    • COI: 1:CAS:528:DC%2BC2cXpsFCgurc%3D, PID: 24673341
    • Abcouwer SF, Gardner TW (2014) Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment. Ann N Y Acad Sci 1311:174–190
    • (2014) Ann N Y Acad Sci , vol.1311 , pp. 174-190
    • Abcouwer, S.F.1    Gardner, T.W.2
  • 6
    • 84890989082 scopus 로고    scopus 로고
    • Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives
    • PID: 24183659
    • Simó R, Hernández C, European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) (2014) Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab 25:23–33
    • (2014) Trends Endocrinol Metab , vol.25 , pp. 23-33
    • Simó, R.1    Hernández, C.2
  • 7
    • 36048980250 scopus 로고    scopus 로고
    • Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration
    • COI: 1:CAS:528:DC%2BD2sXhtlKhs7vI, PID: 17704349
    • Carrasco E, Hernández C, Miralles A, Huguet P, Farrés J, Simó R (2007) Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care 30:2902–2908
    • (2007) Diabetes Care , vol.30 , pp. 2902-2908
    • Carrasco, E.1    Hernández, C.2    Miralles, A.3    Huguet, P.4    Farrés, J.5    Simó, R.6
  • 8
    • 70949094028 scopus 로고    scopus 로고
    • Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy
    • PID: 19823802
    • Garcia-Ramírez M, Hernández C, Villarroel M et al (2009) Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy. Diabetologia 52:2633–2641
    • (2009) Diabetologia , vol.52 , pp. 2633-2641
    • Garcia-Ramírez, M.1    Hernández, C.2    Villarroel, M.3
  • 9
    • 84962147366 scopus 로고    scopus 로고
    • Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes
    • PID: 26384381
    • Hernández C, Bogdanov P, Corraliza L et al (2016) Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes. Diabetes 65:172–187
    • (2016) Diabetes , vol.65 , pp. 172-187
    • Hernández, C.1    Bogdanov, P.2    Corraliza, L.3
  • 10
    • 35748957503 scopus 로고    scopus 로고
    • The physiology of glucagon-like peptide 1
    • COI: 1:CAS:528:DC%2BD2sXhtlaqu7jI, PID: 17928588
    • Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87:1409–1439
    • (2007) Physiol Rev , vol.87 , pp. 1409-1439
    • Holst, J.J.1
  • 11
    • 84883235805 scopus 로고    scopus 로고
    • Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes
    • PID: 23474487
    • Hernández C, García-Ramírez M, Corraliza L et al (2013) Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes. Diabetes 62:2569–2578
    • (2013) Diabetes , vol.62 , pp. 2569-2578
    • Hernández, C.1    García-Ramírez, M.2    Corraliza, L.3
  • 12
    • 4344652909 scopus 로고    scopus 로고
    • Standard for clinical electroretinography (2004 update)
    • PID: 15455793
    • Marmor MF, Holder GE, Seeliger MW, Yamamoto S, International Society for Clinical Electrophysiology of Vision (2004) Standard for clinical electroretinography (2004 update). Doc Ophthalmol 108:107–114
    • (2004) Doc Ophthalmol , vol.108 , pp. 107-114
    • Marmor, M.F.1    Holder, G.E.2    Seeliger, M.W.3    Yamamoto, S.4
  • 13
    • 84901319791 scopus 로고    scopus 로고
    • The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration
    • PID: 24837086
    • Bogdanov P, Corraliza L, Villena JA et al (2014) The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration. PLoS One 9:e97302
    • (2014) PLoS One , vol.9
    • Bogdanov, P.1    Corraliza, L.2    Villena, J.A.3
  • 14
    • 80053946788 scopus 로고    scopus 로고
    • Glial and endothelial blood-retinal barrier responses to amyloid-beta in the neural retina of the rat
    • COI: 1:CAS:528:DC%2BD1MXjt1Chu7o%3D, PID: 19668434
    • Anderson PJ, Watts H, Hille C et al (2008) Glial and endothelial blood-retinal barrier responses to amyloid-beta in the neural retina of the rat. Clin Ophthalmol 2:801–816
    • (2008) Clin Ophthalmol , vol.2 , pp. 801-816
    • Anderson, P.J.1    Watts, H.2    Hille, C.3
  • 15
    • 0035096388 scopus 로고    scopus 로고
    • Sensitive blood–retinal barrier breakdown quantitation using Evans blue
    • COI: 1:STN:280:DC%2BD3M7lt1CitA%3D%3D, PID: 11222542
    • Xu Q, Qaum T, Adamis AP (2001) Sensitive blood–retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci 42:789–794
    • (2001) Invest Ophthalmol Vis Sci , vol.42 , pp. 789-794
    • Xu, Q.1    Qaum, T.2    Adamis, A.P.3
  • 16
    • 0037250362 scopus 로고    scopus 로고
    • Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules
    • Xu H, Forrester JV, Liversidge J, Crane I (2003) Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules. J Invest Ophthalmol Vis Sci 44:226–234
    • (2003) J Invest Ophthalmol Vis Sci , vol.44 , pp. 226-234
    • Xu, H.1    Forrester, J.V.2    Liversidge, J.3    Crane, I.4
  • 17
    • 78149441695 scopus 로고    scopus 로고
    • Betacellulin induces increased retinal vascular permeability in mice
    • PID: 20976146
    • Anand-Apte B, Ebrahem Q, Cutler A et al (2010) Betacellulin induces increased retinal vascular permeability in mice. PLoS One 5:e13444
    • (2010) PLoS One , vol.5
    • Anand-Apte, B.1    Ebrahem, Q.2    Cutler, A.3
  • 18
    • 84862520770 scopus 로고    scopus 로고
    • Fiji: an open-source platform for biological-image analysis
    • COI: 1:CAS:528:DC%2BC38XhtVKnurbJ, PID: 22743772
    • Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682
    • (2012) Nat Methods , vol.9 , pp. 676-682
    • Schindelin, J.1    Arganda-Carreras, I.2    Frise, E.3
  • 19
    • 79960204200 scopus 로고    scopus 로고
    • Measurement of plasma amino acids by ultraperformance liquid chromatography
    • COI: 1:CAS:528:DC%2BC3MXhtVKqtLnE, PID: 21722078
    • Narayan SB, Ditewig-Meyers G, Graham KS, Scott R, Bennett MJ (2011) Measurement of plasma amino acids by ultraperformance liquid chromatography. Clin Chem Lab Med 49:1177–1185
    • (2011) Clin Chem Lab Med , vol.49 , pp. 1177-1185
    • Narayan, S.B.1    Ditewig-Meyers, G.2    Graham, K.S.3    Scott, R.4    Bennett, M.J.5
  • 20
    • 0032480888 scopus 로고    scopus 로고
    • Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
    • PID: 9853756
    • de Rooij J, Zwartkruis FJ, Verheijen MH et al (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474–477
    • (1998) Nature , vol.396 , pp. 474-477
    • de Rooij, J.1    Zwartkruis, F.J.2    Verheijen, M.H.3
  • 21
    • 24144444059 scopus 로고    scopus 로고
    • Epac1 regulates integrity of endothelial cell junctions through VE-cadherin
    • COI: 1:CAS:528:DC%2BD2MXpvV2rurk%3D, PID: 16115630
    • Kooistra MR, Corada M, Dejana E, Bos JL (2005) Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 579:4966–4972
    • (2005) FEBS Lett , vol.579 , pp. 4966-4972
    • Kooistra, M.R.1    Corada, M.2    Dejana, E.3    Bos, J.L.4
  • 22
    • 79955789030 scopus 로고    scopus 로고
    • Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications
    • COI: 1:CAS:528:DC%2BC3MXmtFygt7o%3D, PID: 21402149
    • Breckler M, Berthouze M, Laurent AC, Crozatier B, Morel E, Lezoualc’h F (2011) Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications. Cell Signal 23:1257–1266
    • (2011) Cell Signal , vol.23 , pp. 1257-1266
    • Breckler, M.1    Berthouze, M.2    Laurent, A.C.3    Crozatier, B.4    Morel, E.5    Lezoualc’h, F.6
  • 23
    • 84862687124 scopus 로고    scopus 로고
    • VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost
    • COI: 1:CAS:528:DC%2BC38XovVGmtbc%3D, PID: 22213015
    • Birukova AA, Tian Y, Dubrovskyi O et al (2012) VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost. J Cell Physiol 227:3405–3416
    • (2012) J Cell Physiol , vol.227 , pp. 3405-3416
    • Birukova, A.A.1    Tian, Y.2    Dubrovskyi, O.3
  • 24
    • 84900547141 scopus 로고    scopus 로고
    • Drug delivery to the back of the eye following topical administration: an update on research and patenting activity
    • COI: 1:CAS:528:DC%2BC2cXos1Gqtr4%3D, PID: 24475918
    • Boddu SHS, Gupta H, Patel S (2014) Drug delivery to the back of the eye following topical administration: an update on research and patenting activity. Recent Pat Drug Deliv Formul 8:27–36
    • (2014) Recent Pat Drug Deliv Formul , vol.8 , pp. 27-36
    • Boddu, S.H.S.1    Gupta, H.2    Patel, S.3
  • 25
    • 85019559864 scopus 로고    scopus 로고
    • GLP-1 as a target for the treatment of diabetic retinopathy: friend or foe?
    • Simó R, Hernández C (2017) GLP-1 as a target for the treatment of diabetic retinopathy: friend or foe? Diabetes 66:1–8
    • (2017) Diabetes , vol.66 , pp. 1-8
    • Simó, R.1    Hernández, C.2
  • 26
    • 85006173480 scopus 로고    scopus 로고
    • The DPP4 inhibitor linagliptin protects from experimental diabetic retinopathy
    • PID: 27942008
    • Dietrich N, Kolibabka M, Busch S et al (2016) The DPP4 inhibitor linagliptin protects from experimental diabetic retinopathy. PLoS One 11:e0167853
    • (2016) PLoS One , vol.11
    • Dietrich, N.1    Kolibabka, M.2    Busch, S.3
  • 27
    • 84903899012 scopus 로고    scopus 로고
    • Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2
    • COI: 1:CAS:528:DC%2BC2cXht1Oru77K, PID: 24928308
    • Wronkowitz N, Görgens SW, Romacho T et al (2014) Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2. Biochim Biophys Acta 1842:1613–1621
    • (2014) Biochim Biophys Acta , vol.1842 , pp. 1613-1621
    • Wronkowitz, N.1    Görgens, S.W.2    Romacho, T.3
  • 28
    • 84942988245 scopus 로고    scopus 로고
    • Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis
    • COI: 1:CAS:528:DC%2BC2MXht1Krt7zI, PID: 26175140
    • Zhang H, Maqsudi S, Rainczuk A et al (2015) Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis. FEBS J 282:3737–3757
    • (2015) FEBS J , vol.282 , pp. 3737-3757
    • Zhang, H.1    Maqsudi, S.2    Rainczuk, A.3
  • 29
    • 84859444000 scopus 로고    scopus 로고
    • Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model
    • PID: 22151893
    • Gonçalves A, Leal E, Paiva A et al (2012) Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model. Diabetes Obes Metab 14:454–463
    • (2012) Diabetes Obes Metab , vol.14 , pp. 454-463
    • Gonçalves, A.1    Leal, E.2    Paiva, A.3
  • 30
    • 84888212579 scopus 로고    scopus 로고
    • Beneficial effects of vildagliptin on retinal injury in obese type 2 diabetic rats
    • COI: 1:CAS:528:DC%2BC3sXhslCmt7bL, PID: 24081217
    • Maeda S, Yamagishi S, Matsui T et al (2013) Beneficial effects of vildagliptin on retinal injury in obese type 2 diabetic rats. Ophthalmic Res 50:221–226
    • (2013) Ophthalmic Res , vol.50 , pp. 221-226
    • Maeda, S.1    Yamagishi, S.2    Matsui, T.3
  • 31
    • 84903487864 scopus 로고    scopus 로고
    • Dipeptidyl peptidase-IV inhibition prevents blood retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats
    • PID: 24769045
    • Gonçalves A, Marques C, Leal E et al (2014) Dipeptidyl peptidase-IV inhibition prevents blood retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats. Biochim Biophys Acta 1842:1454–1463
    • (2014) Biochim Biophys Acta , vol.1842 , pp. 1454-1463
    • Gonçalves, A.1    Marques, C.2    Leal, E.3
  • 32
    • 84978110502 scopus 로고    scopus 로고
    • Dipeptidyl peptidase-4 inhibitor increases vascular leakage in retina through VE-cadherin phosphorylation
    • COI: 1:CAS:528:DC%2BC28XhtFGmu7nJ, PID: 27381080
    • Lee CS, Kim YG, Cho HJ et al (2016) Dipeptidyl peptidase-4 inhibitor increases vascular leakage in retina through VE-cadherin phosphorylation. Sci Rep 6:29393
    • (2016) Sci Rep , vol.6 , pp. 29393
    • Lee, C.S.1    Kim, Y.G.2    Cho, H.J.3
  • 33
    • 84892386243 scopus 로고    scopus 로고
    • Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes
    • PID: 24423149
    • Ott C, Raff U, Schmidt S et al (2014) Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes. Cardiovasc Diabetol 13:19
    • (2014) Cardiovasc Diabetol , vol.13 , pp. 19
    • Ott, C.1    Raff, U.2    Schmidt, S.3
  • 34
    • 84994813253 scopus 로고    scopus 로고
    • Semaglutide in cardiovascular outcomes in patients with type 2 diabetes
    • COI: 1:CAS:528:DC%2BC28XhvF2ksrfK, PID: 27633186
    • Marso SP, Bain SC, Consoli A et al (2016) Semaglutide in cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 375:1834–1844
    • (2016) N Engl J Med , vol.375 , pp. 1834-1844
    • Marso, S.P.1    Bain, S.C.2    Consoli, A.3
  • 35
    • 64449087059 scopus 로고    scopus 로고
    • Protection of exendin-4 analogue in early experimental diabetic retinopathy
    • COI: 1:CAS:528:DC%2BD1MXjvFOiu7Y%3D, PID: 19084986
    • Zhang Y, Wang Q, Zhang J, Lei X, Xu G-T, Ye W (2009) Protection of exendin-4 analogue in early experimental diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 247:699–706
    • (2009) Graefes Arch Clin Exp Ophthalmol , vol.247 , pp. 699-706
    • Zhang, Y.1    Wang, Q.2    Zhang, J.3    Lei, X.4    Xu, G.-T.5    Ye, W.6
  • 36
    • 79952230999 scopus 로고    scopus 로고
    • Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats
    • COI: 1:CAS:528:DC%2BC3MXmsVShtb8%3D, PID: 20688733
    • Zhang Y, Zhang J, Wang Q et al (2011) Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats. Invest Ophthalmol Vis Sci 52:278–285
    • (2011) Invest Ophthalmol Vis Sci , vol.52 , pp. 278-285
    • Zhang, Y.1    Zhang, J.2    Wang, Q.3
  • 37
    • 84865250066 scopus 로고    scopus 로고
    • Protection of exenatide for retinal ganglion cells with different glucose concentrations
    • PID: 22727809
    • Fu Z, Kuang HY, Hao M, Gao XY, Liu Y, Shao N (2012) Protection of exenatide for retinal ganglion cells with different glucose concentrations. Peptides 37:25–31
    • (2012) Peptides , vol.37 , pp. 25-31
    • Fu, Z.1    Kuang, H.Y.2    Hao, M.3    Gao, X.Y.4    Liu, Y.5    Shao, N.6
  • 38
    • 84908703140 scopus 로고    scopus 로고
    • Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis
    • Fan Y, Liu K, Wang Q, Ruan Y, Zhang Y, Ye W (2014) Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis. Mol Vis 10:1557–1568
    • (2014) Mol Vis , vol.10 , pp. 1557-1568
    • Fan, Y.1    Liu, K.2    Wang, Q.3    Ruan, Y.4    Zhang, Y.5    Ye, W.6
  • 39
    • 84905275412 scopus 로고    scopus 로고
    • Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats
    • COI: 1:CAS:528:DC%2BC2cXht1ymurrI, PID: 24910901
    • Fan Y, Liu K, Wang Q, Ruan Y, Ye W, Zhang Y (2014) Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats. Exp Eye Res 127:104–116
    • (2014) Exp Eye Res , vol.127 , pp. 104-116
    • Fan, Y.1    Liu, K.2    Wang, Q.3    Ruan, Y.4    Ye, W.5    Zhang, Y.6
  • 40
    • 84989952584 scopus 로고    scopus 로고
    • The glucagon like peptide 1 analogue, exendin-4, attenuated oxidative stress-induced retinal cell death in early diabetic rats through promoting Sirt1 and Sirt3 expression
    • COI: 1:CAS:528:DC%2BC28XhsFyrurbJ, PID: 27212443
    • Zeng Y, Yang K, Wang F et al (2016) The glucagon like peptide 1 analogue, exendin-4, attenuated oxidative stress-induced retinal cell death in early diabetic rats through promoting Sirt1 and Sirt3 expression. Exp Eye Res 151:203–211
    • (2016) Exp Eye Res , vol.151 , pp. 203-211
    • Zeng, Y.1    Yang, K.2    Wang, F.3
  • 41
    • 0031729874 scopus 로고    scopus 로고
    • Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial
    • The Diabetes Control and Complications Trial Research Group (1998) Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 116:874–886
    • (1998) Arch Ophthalmol , vol.116 , pp. 874-886


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.